Chris@NNW, Author at NetworkNewsWire

TuesdayAug 08, 2017 3:26 pm

ARCA Biopharma, Inc. (NASDAQ: ABIO) Brings Precision Medicine Closer to Reality

Drug candidate for top cause of death in the United States Genetically-targeted therapy increases chances of recovery Interim efficacy analysis soon to be conducted by the Data Safety Monitoring Board Atrial fibrillation affects up to six million people in the U.S. The condition, if untreated, can lead to blood clots, stroke, heart failure and other heart-related complications, but many medications currently in use to treat it come with worrying side effects, perhaps because of their one-size-fits-all approach. In an effort to mitigate the unwanted, unintended action of these agents, ARCA Biopharma, Inc. (NASDAQ: ABIO) is applying a precision medicine approach, developing…

TuesdayAug 08, 2017 2:41 pm

Net Element, Inc. (NASDAQ: NETE) Proposes a Reverse Split of its Common Stock to Increase Valuation

Proxy to shareholders seeks a reduction in Net Element's common shares from 400 million to 100 million NETE reaches 30-month term stock purchase agreement with Cobblestone Partners Sets August 10 meeting with NASDAQ to present plan for listing compliance Net Element, Inc. (NASDAQ: NETE) has proposed to shareholders a reverse split of its common stock at a ratio of between 1-for-10 and 1-for-30 on the proxy at its annual meeting in 2017 (http://nnw.fm/5DUxz). It also plans to put to a vote of shareholders a reduction in common stock from 400 million shares to 100 million shares in the hope that…

TuesdayAug 08, 2017 11:57 am

InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Findings Set Stage for Future Cannabinoid Compound Studies

Fundamental value drivers of InMed Pharmaceuticals are its drug development pipeline and proprietary biosynthesis technology in cannabinoid manufacturing Biopharmaceutical company already has two drug candidates – INM-085 and INM-750 – in the multi-billion dollar ocular and dermatology markets INM-085 and INM-750 target markets valued in excess of $5 billion and $1 billion, respectively InMed Pharmaceuticals, Inc.’s (CSE: IN) (OTCQB: IMLFF) study, which generated an article published in the European Journal of Pain (http://nnw.fm/SVF1j), sets the stage for more research into how a topically-applied drug can provide relief of chronic or acute pain without central side effects, according to Dr. Sazzad…

TuesdayAug 08, 2017 9:00 am

Absent Federal Banking Support, Cannabis Market Shows Growing Interest in Proprietary Bitcoin Payment Solutions

NetworkNewsWire Editorial Coverage: The legal marijuana industry continues its impressive growth, despite the inability to access a wide range of banking solutions, given that cannabis is still classified as a Schedule I substance by the Federal government. Similarly, bitcoin is a booming market, recently hitting an all-time high of $3,0001 per unit. These two fast-growing markets are already working together, providing investors with significant and diversified opportunities. Several companies, such as SinglePoint, Inc. (SING), First Bitcoin Capital Corp. (BITCF), Epazz, Inc. (EPAZ) and Bitcoin Services, Inc. (BTSC), are focused on innovative bitcoin-based payment solutions to benefit the legal marijuana industry…

MondayAug 07, 2017 2:56 pm

Moxian, Inc. (NASDAQ: MOXC) Taking Initiative on Generational Opportunity

New Chinese economy has produced new Chinese consumer Consumer has pent up demand Moxian provides platform to motivate and move consumers to retail outlets There’s little doubt that economic forces have transformed the Chinese consumer markets. The meteoric rise of middle-class households, a new generation of tech savvy consumers and the powerful pull of e-commerce all promise immense new consumer opportunities in China. A long time in the making, China’s consumer class has arrived. China’s state run economy has pushed and pulled the country from subsistence agrarians to leading edge high-tech manufacturing with workers and consumers evolving along the way. …

MondayAug 07, 2017 1:56 pm

Moleculin Biotech (NASDAQ: MBRX) to Begin Preparing Clinical Testing Sites for Leukemia Treatment

NASDAQ Biotechnology Index up and climbing Developing new treatment for acute myeloid leukemia (AML) Lead candidate, Annamycin, now at phase II Since a rising sea lifts all boats, it’s decidedly good news for Moleculin Biotech, Inc. (NASDAQ: MBRX) that the NASDAQ Biotechnology Index (NBI) is enjoying a spring tide. The index has offered a year-to-date return of over 17 percent and seems set to keep climbing. This benign environment gives Moleculin an opportunity to advance work on its leading anti-cancer drug candidates. The company has begun to identify and prepare testing sites in Europe and has already appointed a Lead…

MondayAug 07, 2017 12:42 pm

Medical Innovation Holdings, Inc. (MIHI) Serving the Underserved with Telemedicine

Millions of Americans live in areas with little or no comprehensive health care MIHI establishing nationwide telemedicine network to provide specialty care Serving the underserved makes MIHI sole practitioner to millions There’s no doubt that the U.S. health care system is fractured. Our patchwork quilt of health care services leaves many citizens isolated and medically stranded. Far beyond the current contentious health care debate, millions of Americans live in areas that have chronically suffered with little or no health care services. For various reasons of geography, economics or social circumstance, certain populations in the country have far too few primary…

MondayAug 07, 2017 12:04 pm

Qualstar Corp. (NASDAQ: QBAK) – Serving One of the Most Foundational Technical Markets on Earth

Huge and exponentially growing global need Industry independent Established reputation for reliability and cost-effectiveness If there’s one challenge that dominates almost every aspect of our modern information age, it is most certainly Big Data. Over and above the increasing number of ways Big Data can be processed and analyzed, depending upon the need, the most fundamental problem is the sheer storing of exponentially growing volumes of data produced by virtually every industry and institution. With the skyrocketing number of technologies and applications available to individuals and organizations for capturing and digitizing visual, audio, text, numeric, and every other conceivable type…

FridayAug 04, 2017 2:18 pm

India Globalization Capital, Inc. (NYSE: IGC) – Blockbuster Position for Treating Alzheimer’s

IGC purchased exclusive rights to USF patent focused on preventing amyloid-beta plaques from aggregating on neurons Company plans to pursue clinical trials related to this patent on path to FDA approval In 2017, direct costs associated with Alzheimer's and other dementias will total an estimated $259 billion, according to the Alzheimer's Association If you are an investor, there have been significant developments over the past year that you should be tracking. These include remarkable, if preliminary, results regarding the effect of THC on amyloid-beta plaques, the plaques on neurons associated with Alzheimer’s disease, as well as a critical link between…

ThursdayAug 03, 2017 1:49 pm

Origo Acquisition Corp. (NASDAQ: OACQ) to Acquire High Times Holding Corp.

Origo to acquire High Times in transaction valued at $250 million High Times will be traded under Origo’s ticker symbol following close of acquisition Better access to capital and an elevated profile will enable High Times to expand its brand and fund new opportunities Origo Acquisition Corp. (NASDAQ: OACQ) is acquiring the iconic marijuana media company High Times Holding Corp. in a move that allows High Times to become publicly traded, according to a MarketWatch article published July 31 (http://nnw.fm/2Omt9). Origo will acquire all of High Times’ equity in a transaction valued at $250 million. Origo will give 23.5 million…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

Author: Chris@NNW